The US company and its German partner BioNTech are seeking approval to use booster doses of their COVID-19 vaccines for people aged 16 and over. They hope to complete the procedures by the end of the week.
The US government said it is preparing to approve and administer a third dose of the vaccine from mid-September to Americans who took their first two doses of Pfizer/BioNTech more than eight months ago.
As noted by Reuters, Israel made the decision to offer a third dose of the COVID-19 vaccine to people in their 60s on July 30 this year. As of Thursday, the third dose can also be given to younger people over the age of 40. All thanks to the highly contagious variant of the coronavirus – Delta.
US President Joe Biden also expressed support for booster vaccines. “This is the best way to guard against new variables that may emerge,” Biden said.
However, WHO Director-General Tedros Adhanom Ghebreyesus emphasized that data on the benefits and safety of a booster dose of COVID-19 vaccines are inconclusive. The World Health Organization has again called for refraining from introducing third doses of vaccines, and instead to pursue higher vaccination rates in countries where many did not receive the first dose.
The World Health Organization expects governments to postpone decisions at least until the end of September.
The third dose of the Pfizer-BioNTech vaccine is not currently approved for use in the United States. However, under the revised Emergency Permit, a third dose may be given to immunocompromised individuals (but not under 12 years of age).
“Internet Geek. Food Enthusiast. Thinker. Beer Practitioner. Bacon Specialist. Music Addict. Traveler.”